Literature DB >> 3733723

Kinetic, equilibrium, and spectroscopic studies on dealkylation ("aging") of alkyl organophosphonyl acetylcholinesterase. Electrostatic control of enzyme topography.

H A Berman, M M Decker.   

Abstract

The mechanism of dealkylation ("aging") of branched-alkyl organophosphonyl conjugates of acetylcholinesterase and the consequence of this reaction on enzyme conformation were examined by employing kinetic, equilibrium, and spectroscopic techniques. Aging of cycloheptyl methylphosphono-acetylcholinesterase proceeded as a unimolecular reaction in which the enzyme became refractory to oxime reactivation and was accelerated with increases in temperature and decreases in pH and ionic strength of the medium. While aging occurred in a manner invariant with the nature of the salt in buffers containing Na+, K+, Rb+, Cs+, Cl-, CH3COO-, SO2-(4), and PO3-(4), the influence of ionic strength on aging was opposite to that predicted for a mechanism requiring charge separation during formation of the polar transition state. Examination of the equilibrium enzyme conformation with decidium, a fluorescent active center-selective ligand, revealed marked alterations in ligand association and a greater ionic strength dependence for binding after aging. The explanation for this behavior focuses on the high net negative surface charge of the enzyme and proposes that acetylcholinesterase topography is governed by the strength of electrostatic interactions between charged, contiguous, mobile protein regions within the subunit. As such, these studies reveal a reciprocal relationship between acetylcholinesterase topography, surface charge, and ionic strength of the medium.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3733723

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Structure and dynamics of the active site gorge of acetylcholinesterase: synergistic use of molecular dynamics simulation and X-ray crystallography.

Authors:  P H Axelsen; M Harel; I Silman; J L Sussman
Journal:  Protein Sci       Date:  1994-02       Impact factor: 6.725

2.  Methantheline improves the reactivation by HI 6 of human erythrocyte acetylcholinesterase inhibited by soman in vitro.

Authors:  M Hallek; L Szinicz
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

3.  Differential inhibition of soluble and membrane-bound acetylcholinesterase forms from mouse brain by choline esters with an acyl moiety of an intermediate size.

Authors:  Y Cho; S H Cha; D E Sok
Journal:  Neurochem Res       Date:  1994-07       Impact factor: 3.996

Review 4.  Butyrylcholinesterase for protection from organophosphorus poisons: catalytic complexities and hysteretic behavior.

Authors:  Patrick Masson; Oksana Lockridge
Journal:  Arch Biochem Biophys       Date:  2009-12-11       Impact factor: 4.013

5.  Aging of phosphylated human acetylcholinesterase: catalytic processes mediated by aromatic and polar residues of the active centre.

Authors:  A Shafferman; A Ordentlich; D Barak; D Stein; N Ariel; B Velan
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

6.  Multiple binding sites involved in the effect of choline esters on decarbamoylation of monomethylcarbamoyl- or dimethylcarbamoly-acetylcholinesterase.

Authors:  D E Sok; Y B Kim; S J Choi; C H Jung; S H Cha
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

7.  Electrostatic attraction by surface charge does not contribute to the catalytic efficiency of acetylcholinesterase.

Authors:  A Shafferman; A Ordentlich; D Barak; C Kronman; R Ber; T Bino; N Ariel; R Osman; B Velan
Journal:  EMBO J       Date:  1994-08-01       Impact factor: 11.598

8.  Virtual screening and biological evaluation of piperazine derivatives as human acetylcholinesterase inhibitors.

Authors:  Kavitha Raj Varadaraju; Jajur Ramanna Kumar; Lingappa Mallesha; Archana Muruli; Kikkeri Narasimha Shetty Mohana; Chethan Kumar Mukunda; Umesha Sharanaiah
Journal:  Int J Alzheimers Dis       Date:  2013-10-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.